Sign in

CIK 0000200406

  • Large accelerated filer

JOHNSON & JOHNSON

Sign in to watch
Ticker
JNJ
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Jan 3
Incorporated
NJ
Entity type
Operating
EIN
221024240
Phone
+1 732-524-2455
Business address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
Former names
JOHNSON & JOHNSON ET AL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,947,986
in 2 filings

Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-10 HEWSON MARILLYN A Director Grant or award · Deferred Share Units +302.55 $165.94 $50K 10,954.94
2024-08-30 Decker Robert J VP Corporate Controller Option exercise +5,635 $100.06 $564K 24,608
2024-08-30 Decker Robert J VP Corporate Controller Sale −5,635 $165.06 $930K 18,973
2024-08-30 Decker Robert J VP Corporate Controller Option exercise · Employee Stock Options (Right to Buy) −5,635 0
2024-07-08 Broadhurst Vanessa EVP, Global Corp Affairs Option exercise +9,809 24,852
2024-07-08 Broadhurst Vanessa EVP, Global Corp Affairs Shares withheld for taxes −5,018 $147.16 $738K 19,834
2024-07-08 Broadhurst Vanessa EVP, Global Corp Affairs Option exercise · Restricted Share Units −9,809 0
2024-06-04 Woods Eugene A. Director Grant or award · Deferred Share Units +211.36 $147.85 $31K 2,368.45
2024-06-04 HEWSON MARILLYN A Director Grant or award · Deferred Share Units +314.62 $147.85 $47K 10,573.38
2024-05-22 Wolk Joseph J Exec VP, CFO Gift −55 68,835
2024-05-01 REED JOHN C EVP, Innovative Medicine, R&D Option exercise +25,255 25,561
2024-05-01 REED JOHN C EVP, Innovative Medicine, R&D Shares withheld for taxes −10,984 $144.59 $1.6M 14,577
2024-05-01 REED JOHN C EVP, Innovative Medicine, R&D Option exercise · Restricted Share Units −25,255 50,510
2024-05-01 REED JOHN C EVP, Innovative Medicine, R&D Option exercise +22,255 22,561
2024-05-01 REED JOHN C EVP, Innovative Medicine, R&D Shares withheld for taxes −10,984 $144.59 $1.6M 11,577
2024-05-01 REED JOHN C EVP, Innovative Medicine, R&D Option exercise · Restricted Share Units −22,255 53,510
2024-04-25 DAVIS D SCOTT Director Grant or award · Deferred Share Units +1,385.7 15,603.68
2024-04-25 Beckerle Mary C Director Grant or award · Deferred Share Units +1,385.7 13,643.01
2024-04-25 HEWSON MARILLYN A Director Grant or award · Deferred Share Units +1,385.7 10,173.44
2024-04-25 Adamczyk Darius Director Grant or award · Deferred Share Units +1,385.7 3,712.7

Page 25 of 33 · 658 trades